SCHEMBL22322007

SCHEMBL22322007

O=P(O)(OCCCc1ccccc1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.49
LMNA P02545 1/20 0.49
PKM P14618 1/20 0.48
TSHR P16473 2/20 0.47
IDO1 P14902 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.44
FFAR1 O14842 1/20 0.44
NPC1 O15118 1/20 0.44
RECQL P46063 1/20 0.44
RAB9A P51151 1/20 0.44
HDAC3 O15379 2/20 0.43
HDAC4 P56524 2/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC7 Q8WUI4 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC10 Q969S8 2/20 0.43
HDAC11 Q96DB2 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
HDAC9 Q9UKV0 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL11707544 0.84 MEN1 (0.50) LMNATSHRSMN1; SMN2NPC1HDAC3
SCHEMBL17333279 0.84 TSHR (0.60) L3MBTL1LMNAPKMTSHRIDO1
SCHEMBL759323 0.84 LMNA (0.53) L3MBTL1LMNAPKMTSHRIDO1
SCHEMBL15732278 0.83 CA2 (0.52) LMNAPKMTSHRSMN1; SMN2
SCHEMBL22322006 0.82 L3MBTL1 (0.51) L3MBTL1LMNAPKMTSHRIDO1
SCHEMBL9417100 0.81 CA2 (0.43) LMNATSHRSMN1; SMN2
SCHEMBL342877 0.81 MEN1 (0.53)
SCHEMBL7377076 0.81 L3MBTL1 (0.54) L3MBTL1LMNAPKMTSHRIDO1
SCHEMBL16395023 0.80 L3MBTL1 (0.55) L3MBTL1LMNAPKMTSHRIDO1
SCHEMBL776512 0.79 LPAR3 (0.52) TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10927135-B2 Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS (US) 2021-02-23 US disclosed
US-20200255461-A1 METAL-FREE DIRECT ARYLATION OF DIALKYL PHOSPHONATES FOR THE SYNTHESIS OF MIXED ALKYL ARYL PHOSPHONATES THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2020-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255461-A1 METAL-FREE DIRECT ARYLATION OF DIALKYL PHOSPHONATES FOR THE SYNTHESIS OF MIXED ALKYL ARYL PHOSPHONATES SLC35B2, PPIP5K2, PPA1 L3MBTL1 4127/4885LMNA 4753/4885PKM 571/4885
US-10927135-B2 Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates SLC35B2, PPIP5K2, PPA1 L3MBTL1 4127/4885LMNA 4753/4885PKM 571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.